Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study

Masatoshi Kudo, Kazuomi Ueshima, Stephan Chan, +17

Cancers

RUNX3, A Novel Tumor Suppressor, Is Frequently Inactivated in Gastric Cancer by Protein Mislocalization

Kosei Ito, Qiang Liu, Manuel Salto‐Tellez, +14

Cancer Research

Protein MislocalizationGastrointestinal OncologyMedicinePathologyCancer Biology +11

The RUNX3 Tumor Suppressor Upregulates Bim in Gastric Epithelial Cells Undergoing Transforming Growth Factorβ-Induced Apoptosis

Takashi Yano, Kosei Ito, Hiroshi Fukamachi, +8

Molecular and Cellular Biology

Cancer ResearchHuman Bim PromoterProapoptotic Gene BimGastrointestinal OncologyMedicine +10

Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia

Atsushi Yamada, Takahiro Horimatsu, Yoshinaga Okugawa, +17

Clinical Cancer Research

RUNX3 Cooperates with FoxO3a to Induce Apoptosis in Gastric Cancer Cells

Yasuko Yamamura, Wei Lin Lee, Ken‐ichi Inoue, +2

Journal of Biological Chemistry

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study

Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara, +14

Cancers

Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3

Sing‐Huang Tan, Hiroshi Ida, Quek-Choon Lau, +4

Oncology Reports

Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study

Masatoshi Kudo, Tomoko Aoki, Kazuomi Ueshima, +19

Liver Cancer

Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease

Reiko Akitake, Tomohiro Watanabe, C. Zaima, +4

Gut

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines

Manabu Wada, Shujiro Yazumi, Shigeo Takaishi, +8

Oncogene

Tumor BiologyPancreatic CancerMedicineBiliary CancerPathology +7